| Management target | Revenue FY27 |
|---|
| Revenue growth | 67.6% YoY to INR 173.6 Cr. |
|---|---|
| Margins | Short-term pressure from input costs; expected recovery in 2 quarters. |
| Demand visibility | Strong SSG and increasing consumer acceptance of generics. |
| Management confidence | High; confident in meeting 650 store addition target. |
Growth
Revenue grew 67.6% YoY to INR 17,360 lakhs. Gross margins improved to 61.96%.
Outlook
Targeting 600-650 new store additions in FY27. Projecting annual marketing spend of INR 40-45Cr.
Risks
Temporary margin pressure due to high input costs and geopolitical issues; significantly increased marketing spend (INR 15-17Cr).
Last quarter's promises, checked
Delivered
- Guided 200+ store additions in Q1 → delivered 264 (= BEAT)
- Guided 25-30% SSG for mature stores → delivered 24-30% range (= BEAT)
- Guided sustainable 60%+ gross margins → delivered 61.96% (= BEAT)
Partly delivered
- Guided FY27 500-700 store target → 264 added (on track) (= PARTIAL)
Missed
- Guided EBITDA positivity turnaround → delivered temporary margin pressure/loss (= MISS)
Earnings Call Transcript filed with NSE, NSE: ZOTA. Summary written with AI assistance from the document.
Zota Healthcare Ltd: key numbers
- Share price
- ₹1,336.60
- Market cap
- ₹4,629 Cr
- Revenue (annual)
- ₹538.7 Cr
- Net profit (annual)
- ₹-73.94 Cr
- P/E (TTM)
- -44.9×Sector 50.4×
- Promoter holding
- 49.38%+0.00% QoQ
- FII holding
- 7.91%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Zota Healthcare Ltd
All →Zota Healthcare Annual General Meeting
Zota Health Care responded to a proxy advisory firm's negative recommendations on upcoming AGM resolutions, defending proposed director remuneration and related party transactions with its subsidiary.
Zota Healthcare Management Change
Zota Health Care Limited announced the cessation of Mrs. Varshabahen Gaurang Mehta as an Independent Director effective September 09, 2026, upon the completion of her tenure.
Zota Healthcare Management Change
Zota Health Care Limited appointed Mr. Mahaveer Dhariwal as a Non-Executive Independent Director, effective September 3, 2026. The board approved this leadership appointment.
Zota Healthcare Annual General Meeting
Zota Health Care has fixed September 21, 2026, as the record date for its upcoming Annual General Meeting and final dividend payment.
Zota Healthcare Board Meeting Outcome
Zota Health Care Limited's board approved the Notice of the 26th AGM and set the record date for the final dividend. They also appointed a new Independent Director.
Zota Healthcare Investor Presentation: Key Takeaways
Zota Health Care's Q1FY27 presentation highlights its massive Davaindia retail generic pharmacy expansion, now reaching 2,825 stores and driving 83% of company revenue.